| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |